10 results
IDSA - Prophylaxis to Prevent First Episode of Opportunistic Disease in HIV-AIDS
 • Pneumocystis pneumonia (PCP)
Opportunistic Disease in HIV-AIDS ... tuberculosis infection (TB ... Papillomavirus (HPV ... Hepatitis A virus (HAV ... IDSA #management #pharmacology
IDSA - Prophylaxis to Prevent First Episode of Opportunistic Disease in HIV-AIDS
 • Pneumocystis pneumonia (PCP)
Opportunistic Disease in HIV-AIDS ... tuberculosis infection (TB ... Papillomavirus (HPV ... Hepatitis A virus (HAV ... IDSA #management #pharmacology
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
: • HIV • Recent ... bacteremia, and miliary ... are pulmonary • HIV ... Hematogenous spread -> Miliary ... : • HIV-infected
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
: • HIV • Recent ... bacteremia, and miliary ... are pulmonary • HIV ... Hematogenous spread -> Miliary ... : • HIV-infected
Emergency Treatment Algorithm for Convulsive Status Epilepticus
1. ABCDEFG (ABC's and Don't Ever Forget the Glucose)
2. Airway:
Airway: lateral ... IV access 4. ... Lorazepam 0.1 mg/kg IV ... 200 mg q12h PO/IV ... Management #Neurology #Pharmacology
Management Algorithm for Status Epilepticus

• Assess airway, breathing, and circulation
• Pulse oximetry
• Electrocardiogram
• Finger stick (give
Finger stick (give IV ... Aspiration precautions (lateral ... Midazolam 10 mg IV ... 20 PE/kg IM or IV ... Algorithm #Neurology #pharmacology
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
Candidiasis in HIV-AIDS ... Refer to product label ... 400 mg) PO or IV ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Treating Mycobacterium Tuberculosis Infection and Disease in HIV-AIDS
Treating LTBI (to prevent TB disease)
Indications:
and Disease in HIV-AIDS ... be initiated in HIV-infected ... suggestive of HIV-related ... treatment for HIV-related ... infections #HIVAIDS #pharmacology
Select Antiretroviral and Non–Rifamycin-based Antituberculosis Drug Overlapping Toxicities and Potential Adverse Drug–Drug Interactions
 • Arrhythmias, QT
Skin rash - All TB ... in people with HIV ... #interactions #pharmacology
IDSA Recommendations for Preventing and Treating Disseminated Mycobacterium Avium Complex in HIV-AIDS
Preventing 1st Episode of Disseminated
Avium Complex in HIV-AIDS ... Note: Active TB ... infections #HIVAIDS #pharmacology